Wall Street Cures Its AI Hangover With ‘Hair of the Dogefather’ as $SPCX Rips 7%

By Stocks News   |   4 weeks ago   |   Stock Market News
Wall Street Cures Its AI Hangover With ‘Hair of the Dogefather’ as $SPCX Rips 7%

“Just when I thought I was out, they pull me back in…” - every hedge fund that dumped tech last week

Welp, the AI trade didn’t hear no bell. Last week, Wall Street was puking up chip stocks. By Wednesday, it was taking shots of Elon. Case in point: The Nasdaq climbed 1.1%, the S&P 500 added 0.6%, and the Dow tacked on 271 points (+0.5%).

For starters, SpaceX popped 7% after its Q3 revenue grew 161% to $14.6B, and it swung to a $4.4B profit. Its AI business, now called “Super Intelligence” (because of course it is), grew ninefold to $7.56B and is now bigger than Starlink. Then it guided Q1 2027 revenue to $33-37B (the Street wanted $22.2B), even with capex at $19.6B and up to $40B planned for Q4. Launch revenue came in at $1.77B. Too bad SpaceX isn’t a rocket company anymore (isn’t that right, Elon?).

Oh, and Elon also said SpaceX and Tesla have formed special committees to discuss a merger of equals. Tesla shares rose 3%+ ahead of its Q3 report tonight, where the Street expects EPS to fall about 10% YoY. The stock’s still down roughly 14% this year, so Tim Walz’s least favorite EV maker could use a sugar daddy. 

Naturally, chip stocks rode SpaceX’s big swingin’ AI numbers, too. Jensen’s cousin’s company (read: AMD) jumped almost 4%, while Nvidia, Micron, and Marvell each gained 2%+. Friendly reminder, chips just had their worst week in over a year, the same week Elon replied “Yikes” to a chart of CoreWeave’s 15% bonds. Oh how the turntables.

Which brings us to Zuck. Meta reported after the bell, about a week after launching Muse Wonder, its latest AI model, which is only available to paying users. Meaning, it can now be enjoyed by literally dozens of people. The Street also expects Zuck to have mainlined another ~$41B into capex this quarter.

Meanwhile, Roivant Sciences rose 5% after its immune-modifying pill Lisraya hit its main goals in two Phase 3 trials for non-infectious uveitis (read: eye stuff, I think). The results came months ahead of schedule. As for founder Vivek Ramaswamy, his campaign for Ohio governor is having a worse month than you (he trails Amy Acton 50-43 in the latest Marist poll).

Elsewhere, in stonk land, it was a rare W for the crypto bros. Bitcoin jumped 2% to above $84K (still about a third below last October’s high), and crypto stocks followed, obviously: Strategy pumped 7%, while MARA and Riot mooned 3% and 2%. Fun fact: Strategy bought just 267 bitcoin last week. Turns out Paper Hands Saylor (read: Michael Saylor) doesn’t like big butts buys anymore, and he cannot lie. His ~848.5K coins cost an average of $75,446 each, so he’s only about 11% above water.

So yeah… that was Wednesday. All in all, stonks are back on their bullsh*t. But Zuck and Elon’s car company both grab the mic after the bell, and one wrong word about capex means we’re right back to holding Wall Street’s hair.

Until next time, friends…

If you read all of this, congrats for having a 10 second attention span (better than me). As always, here’s our heatmap for today.

☕ Market Gossip

> Meta ordered to pay $25 billion penalty in New Mexico Cambridge Analytica case (CNBC): Zuck around and find out…

> PHP armageddon: OpenAI, Google’s Wiz find ancient holes, panicking the internet (TechCrunch): AI: *finds a 22-year-old bug before the hackers do*

Also AI: *shows the hackers how to use it*

> Larry Ellison Went on Borrowing Spree to Bankroll His Son’s Warner Bros. Bid (Wall Street Journal): Being a nepo baby remains undefeated.

> Electronic Arts to Shed 400 Jobs, Shut Down BioWare to Cut Costs (Bloomberg): BioWas.

“WTF” Meme of the Day

Future cult leaders take notes…

 

At the time of publishing, Stocks.News holds positions in Meta and Tesla as mentioned in the article. 

 

Did you find this insightful?

Disclaimer: Information provided is for informational purposes only, not investment advice. We do not recommend buying or selling stocks. Stock price discussions are based on publicly available data. Readers should conduct their own research or consult a financial advisor before investing. Owners of this site have current positions in stocks mentioned throughout the site, Please Read Full Disclaimer for details Here https://app.stocks.news/page/disclaimer